Skip to content

Does an Initially Authorised Combination Medicinal Product and a Later Authorised Single Component of that Combination Belong to the Same Global Marketing Authorization? - The Tecfidera® Judgment of the General Court in Case T-611/18

Guram Gobechia

DOI https://doi.org/10.21552/eplr/2021/2/7



Guram Gobechia is an Associate at Novacos Rechtsanwälte. For Correspondence: <guram.gobechia@novacos-law.com>

Related Content

Guram Gobechia
Category: Case Notes


Share


Lx-Number Search

A
|
(e.g. A | 000123 | 01)

Cite this article

Gobechia, G.
Does an Initially Authorised Combination Medicinal Product and a Later Authorised Single Component of that Combination Belong to the Same Global Marketing Authorization? - The Tecfidera® Judgment of the General Court in Case T-611/18
European Pharmaceutical Law Review
Volume 5, Issue 2 (2021)
pp. 102 - 105
DOI: https://doi.org/10.21552/eplr/2021/2/7

Export Citation